Lundbeck
HLUN-B.CO
#2243
Rank
ยฃ6.27 B
Marketcap
ยฃ6.32
Share price
0.89%
Change (1 day)
15.71%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2023 (TTM): ยฃ0.29

According to Lundbeck's latest financial reports the company's current EPS (TTM) is ยฃ0.57. In 2022 the company made an earnings per share (EPS) of ยฃ0.20 a decrease over its 2021 EPS that were of ยฃ0.45.

EPS history for Lundbeck from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)ยฃ0.2946.33%
2022ยฃ0.20-55.47%
2021ยฃ0.45-51.83%
2020ยฃ0.93-28.01%
2019ยฃ1.30-44.08%
2018ยฃ2.3251.94%
2017ยฃ1.53126.64%
2016ยฃ0.67-120.84%
2015-ยฃ3.235622.18%
2014-ยฃ0.05652-110.03%
2013ยฃ0.56-28.08%
2012ยฃ0.78-52.1%
2011ยฃ1.64-1.31%
2010ยฃ1.6615.61%
2009ยฃ1.43